Surgery Websites
Transplant Surgery »  Research »  Clinical Research »  Clinical Trials

Transplant Clinical Trials

Showing 13 Studies
 Also show non-Recruiting Trials
Data provided by UCSF Profiles, powered by CTSI
Study Name
Principal Investigator
Conditions
Interventions
Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)
Study ID: NCT03443869
Accepting New Patients
Flavio Vincenti, M.D.
Cytomegalovirus, Human Cytomegalovirus, Kidney Transplant
Letermovir, Valganciclovir, Acyclovir (ACV), Placebo to ACV, Placebo to LET, Placebo to VGCV
A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients
Study ID: NCT03629080
Accepting New Patients
Flavio Vincenti, M.D.
Cytomegalovirus, Kidney Transplant
HB-101 vaccine, placebo
Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
Study ID: NCT02474667
Accepting New Patients
Flavio Vincenti, M.D.
Delayed Graft Function
ANG-3777, Placebo
Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol
Study ID: NCT02402439
Accepting New Patients
Andrew M. Posselt, M.D., Ph.D.
Diabetes, Diabetes Type 1
Islet cells, Islet transplantation into the gastrointestinal submucosa
Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes
Study ID: NCT03977662
Accepting New Patients
Peter G. Stock, M.D., Ph.D.
Diabetes, Diabetes Type 1
Co-transplantation of PTG with pancreatic islets
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Study ID: NCT02741323
Accepting New Patients
Peter G. Stock, M.D., Ph.D.
HIV/AIDS, Kidney Disease, Kidney Transplant
Maraviroc, Placebo
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Study ID: NCT03500315
Accepting New Patients
Peter G. Stock, M.D., Ph.D.
HIV/AIDS, Kidney Transplant
HIV D+/R+
Treg Modulation With CD28 and IL-6 Receptor Antagonists
Study ID: NCT04066114
Accepting New Patients
Sindhu Chandran, M.D., Flavio Vincenti, M.D.
Kidney Transplant
lulizumab pegol, antithymocyte globulin (rabbit), methylprednisolone, tocilizumab, Prednisone, everolimus, belatacept, mycophenolate mofetil, mycophenolic acid
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Study ID: NCT03663335
Accepting New Patients
Flavio Vincenti, M.D.
Kidney Transplant
CFZ533, Tacrolimus - MMF - +/- corticosteroids
Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
Study ID: NCT03363945
Accepting New Patients
Flavio Vincenti, M.D.
Kidney Transplant, Immunotherapy
MDR-101
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Study ID: NCT02711826
Accepting New Patients
Sindhu Chandran, M.D., Flavio Vincenti, M.D.
Kidney Transplant, Living Kidney Donor
Polyclonal Regulatory T Cells, Everolimus, Tacrolimus, Mycophenolate mofetil, Mycophenolic acid, Acetaminophen, Diphenhydramine, Biopsy, Kidney, Blood Draw, Leukapheresis, IS regimen conversion
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Study ID: NCT03193151
Accepting New Patients
Sandy Feng, M.D., Ph.D.
Liver Disease, Liver Transplant
liver biopsy
OCS Liver PROTECT Continued Access Protocol
Study ID: NCT04186221
Accepting New Patients
Garrett R. Roll, M.D.
Liver Transplant
OCS Liver System
 
Site Directory
    X